Significant Ownership of BAKER BROS. ADVISORS LP

Signature - Title
/s/ Scott L. Lessing - Scott L. Lessing/ President By: Baker Bros. Advisors (GP) LLC, its general partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BAKER BROS. ADVISORS LP.

Notify me when BAKER BROS. ADVISORS LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BAKER BROS. ADVISORS LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KOD Kodiak Sciences Inc. Common Stock, $0.0001 par value per share 33% $357,804,274 20,067,542 Baker Bros. Advisors LP 18 Dec 2025
PRLD Prelude Therapeutics Inc Common Stock, $0.0001 par value per share 24% $8,010,575 10,269,968 Baker Bros. Advisors LP 12 Jun 2025
CELC Celcuity Inc. Common Stock, $0.001 par value per share 19% $85,512,440 +$38,507,045 7,745,692 +82% Baker Bros. Advisors LP 01 Aug 2025
SERA Sera Prognostics, Inc. Class A Common Stock, $0.0001 par value per share 16% $17,869,052 5,498,170 Baker Bros. Advisors LP 12 Feb 2025
REPL Replimune Group, Inc. Common Stock, $0.001 par value per share 14% $80,741,406 11,045,336 Baker Bros. Advisors LP 07 Mar 2025
KYMR Kymera Therapeutics, Inc. Common Stock, $0.0001 par value per share 11% $569,111,115 +$131,852,757 8,676,797 +30% Baker Bros. Advisors LP 09 Dec 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value 0.10 euro per share 10% $490,489,821 +$40,190,632 25,586,190 +8.9% Baker Bros. Advisors LP 12 Jan 2026
KALA KALA BIO, Inc. Common Stock, $0.001 par value per share 10% $11,372,470 744,759 0% Baker Bros. Advisors LP 02 Oct 2025
IMTX Immatics N.V. Ordinary Shares, nominal value EUR 0.01 per share 10% $103,041,681 +$16,402,644 12,094,094 +19% Baker Bros. Advisors LP 30 Sep 2025
RYTM Rhythm Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 8.9% $263,130,477 5,604,483 Baker Bros. Advisors LP 31 Mar 2025
NGNE Neurogene Inc. Common Stock, par value $0.000001 per share 7% $18,685,587 -$9,316,550 991,804 -33% Julian C. Baker 30 Jun 2025
EWTX Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.9% $107,032,021 7,305,940 Baker Bros. Advisors LP 30 Jun 2025
CERS Cerus Corporation Common Stock, par value $0.001 per share 5.2% $15,944,852 -$4,572,043 10,028,209 -22% Julian C. Baker 30 Sep 2025
RVMD Revolution Medicines, Inc. Common Stock, par value $0.0001 per share 5% $358,678,428 9,364,972 Baker Bros. Advisors LP 30 Jun 2025
CADL Candel Therapeutics, Inc. Common Stock, par value $0.01 per share 5% $11,710,865 -$2,513,194 2,455,108 -18% Baker Bros. Advisors LP 31 Mar 2025
BMEA Biomea Fusion, Inc. Common Stock, par value $0.0001 per share 4% $2,511,943 1,451,990 Baker Bros. Advisors LP 31 Dec 2024
IGMS IGM Biosciences, Inc. Common Stock, $0.01 par value per share 0% $0 0 Baker Bros. Advisors LP 14 Aug 2025

Schedules 13D/G Reported by BAKER BROS. ADVISORS LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.